Sven Taylor

585 total citations
15 papers, 410 citations indexed

About

Sven Taylor is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Sven Taylor has authored 15 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Immunology. Recurrent topics in Sven Taylor's work include Receptor Mechanisms and Signaling (7 papers), Mast cells and histamine (3 papers) and Asymmetric Synthesis and Catalysis (3 papers). Sven Taylor is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Mast cells and histamine (3 papers) and Asymmetric Synthesis and Catalysis (3 papers). Sven Taylor collaborates with scholars based in Switzerland, United Kingdom and China. Sven Taylor's co-authors include Peter O’Brien, Steven J. Canipa, Cédric Genet, Jean‐Marc Plancher, Hans Richter, Franz Schuler, Matthias Nettekoven, Peter Hartman, Uwe Grether and Brian Kelly and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Sven Taylor

15 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sven Taylor Switzerland	11	271	148	129	52	49	15	410
John W. Butcher United States	11	199 0.7×	180 1.2×	44 0.3×	33 0.6×	33 0.7×	14	407
Angelica V. Carmona United States	4	292 1.1×	202 1.4×	42 0.3×	37 0.7×	29 0.6×	5	446
John A. Wos United States	13	285 1.1×	249 1.7×	32 0.2×	15 0.3×	27 0.6×	34	565
Peter H. Crackett United Kingdom	9	183 0.7×	91 0.6×	37 0.3×	21 0.4×	40 0.8×	18	295
Kinga Ostrowska Poland	14	264 1.0×	155 1.0×	37 0.3×	46 0.9×	68 1.4×	35	410
Javier García‐Cárceles Spain	8	157 0.6×	154 1.0×	32 0.2×	22 0.4×	13 0.3×	11	368
James W. Darrow United States	6	525 1.9×	272 1.8×	33 0.3×	60 1.2×	37 0.8×	6	672
Ronald G. Sherrill United States	13	343 1.3×	224 1.5×	20 0.2×	33 0.6×	20 0.4×	19	629
Michael McNaughton Belgium	11	160 0.6×	204 1.4×	41 0.3×	20 0.4×	45 0.9×	11	428
Tamara Dejneka United States	9	145 0.5×	114 0.8×	28 0.2×	25 0.5×	29 0.6×	13	264

Countries citing papers authored by Sven Taylor

Since Specialization

Citations

This map shows the geographic impact of Sven Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Taylor more than expected).

Fields of papers citing papers by Sven Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Taylor. The network helps show where Sven Taylor may publish in the future.

Co-authorship network of co-authors of Sven Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Taylor. A scholar is included among the top collaborators of Sven Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Taylor. Sven Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Richter, Hans, G. Martin Benson, Konrad Bleicher, et al.. (2011). Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties. Bioorganic & Medicinal Chemistry Letters. 21(4). 1134–1140. 67 indexed citations

Richter, Hans, G. Martin Benson, Denise Blum, et al.. (2010). Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes. Bioorganic & Medicinal Chemistry Letters. 21(1). 191–194. 49 indexed citations

Richter, Hans, Christian Freichel, Jörg Huwyler, et al.. (2010). Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold. Bioorganic & Medicinal Chemistry Letters. 20(19). 5713–5717. 21 indexed citations

Taylor, Sven. (2010). How many times?. The New Scientist. 205(2743). 23–23. 1 indexed citations

Fettes, Alec, Christian Freichel, Cornelia Hertel, et al.. (2009). 5-Hydroxyindole-2-carboxylic Acid Amides: Novel Histamine-3 Receptor Inverse Agonists for the Treatment of Obesity. Journal of Medicinal Chemistry. 52(13). 3855–3868. 27 indexed citations

Canipa, Steven J., Peter O’Brien, & Sven Taylor. (2009). Catalytic asymmetric deprotonation of a phosphine borane: comparison of two-ligand and one-ligand catalysis. Tetrahedron Asymmetry. 20(20). 2407–2412. 13 indexed citations

Nettekoven, Matthias, et al.. (2009). Selective naphthalene H3 receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs. Bioorganic & Medicinal Chemistry Letters. 19(15). 4495–4500. 16 indexed citations

Canipa, Steven J., et al.. (2008). Catalytic asymmetric deprotonation of phosphine boranes and sulfides as a route to P-stereogenic compounds. Chemical Communications. 3750–3750. 36 indexed citations

Genet, Cédric, Steven J. Canipa, Peter O’Brien, & Sven Taylor. (2006). Catalytic Asymmetric Synthesis of Ferrocenes and P-Stereogenic Bisphosphines. Journal of the American Chemical Society. 128(29). 9336–9337. 128 indexed citations

10.

Nettekoven, Matthias, Wolfgang Guba, Werner Neidhart, et al.. (2005). Aminothiazole Derivatives as Neuropeptide Y5 Receptor Ligands: Finding the Balance between Affinity and Physicochemical Properties. ChemMedChem. 1(1). 45–48. 10 indexed citations

11.

Nettekoven, Matthias, Wolfgang Guba, Werner Neidhart, et al.. (2005). Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor. Bioorganic & Medicinal Chemistry Letters. 15(14). 3446–3449. 10 indexed citations

12.

Adams, David, Sven Taylor, Stephan Röver, et al.. (2004). 5-HT2C Receptor Agonists for the Treatment of Obesity. Biological and Chemical Adventures. CHIMIA International Journal for Chemistry. 58(9). 613–613. 18 indexed citations

13.

Taylor, Sven, Graham J. Riley, Andrea Hunter, et al.. (1999). SB-269652 is a selective D3 receptor antagonist in vitro and in vivo. European Neuropsychopharmacology. 9. 266–266. 6 indexed citations

14.

Barbier, Pierre, et al.. (1998). 8‐Fluoro‐6‐(methoxymethoxy)quinoline: Synthesis and regioselective functionalization via reaction with organolithium compounds. Helvetica Chimica Acta. 81(5-8). 1088–1094. 3 indexed citations

15.

Delaney, Edward J., Ronald G. Sherrill, Venkatapuram A. Palaniswamy, Thomas C. Sedergran, & Sven Taylor. (1994). A reinvestigation of the D-homoannular rearrangement and subsequent degradation pathways of (11β,16α)-9-Fluoro-11,15,17,21-tetrahydroxypregna-1,4-diene-3,20-dione (triamcinolone). Steroids. 59(3). 196–204. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact